CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials

CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Eurotrials, a full-service contract research organization, with more than 20 years of experience, and strong local expertise in Europe and Latin America.

ETisnow CTI (1)

CTI Announces Collaboration with Sernova Corp. for US Phase I/II Cell Pouch Clinical Trial

“We see our collaboration with Sernova on this trial in the growing field of regenerative medicine as having the potential to impact many people with diabetes,” said Tim Schroeder, CEO of CTI. “It is a great opportunity for CTI to collaborate with the experienced team at Sernova and allows us to continue our work in cell therapy, currently representing approximately 40% of CTI’s active research programs.”

Two CTI Executives Honored at C-Suite Awards

Paul Ritter is a finalist in the Chief Legal Officer category, and Kevin Schwarz is a finalist in the Chief Operating Officer category. 

"We are privileged to have such strong leaders on our team," remarks Tim Schroeder, CEO of CTI. "Both Paul and Kevin have played crucial roles in the growth and success of our company over the last 15 years, and we are thrilled to see this well-deserved recognition from the community."

Bexion and CTI Announce Completion of First-in-Human Trial Using BXQ-350 for the Treatment of Cancer

“CTI is extremely happy to partner with Bexion on the development of this novel therapy in patients who desperately need alternative treatments,” stated William Aronstein, PhD, MD, FACP, Vice President, Medical Affairs at CTI. “They are an innovative organization with very strong regional ties – the drug was initially developed and licensed at a local hospital, early funding has predominantly come from the region, and the management and board have strong local connections.”

 

Rare Disease / Orphan Disease

CTI is a leader in rare disease and orphan disease research with the majority of our work falling into this category.

Learn More

Feasibility

When CTI manages study start-up tasks, total start-up time is generally less than half the industry average.

Learn More

Why We Work at CTI

There's a reason we have one of the highest retention rates in the industry. We value our people, and we work hard to make sure our team members know it.

Learn More

Participate in a Trial

Icon Careers Small Retina

CTI CRC is looking for volunteers to participate in our current trials. 

Learn More

Rare Disease Day 2019

Rare Disease Day 2018

CTI is proud to be a partner for Rare Disease Day 2019!

Learn More